1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals: North America (NAFTA) Industry Guide

Pharmaceuticals: North America (NAFTA) Industry Guide

  • January 2016
  • -
  • MarketLine
  • -
  • 84 pages

Introduction

The NAFTA Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ NAFTA operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with forecasts
* Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Highlights

The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $340.0 billion in 2014.The Mexico was the fastest growing country, with a CAGR of 6.6% over the 2010-14 period.
Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $303.9 billion in 2014. This was followed by Canada and Mexico, with a value of $21.6 and $14.4 billion, respectively.
The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $390.7 billion in 2019, followed by Canada and Mexico with expected values of $26.0 and $17.7 billion, respectively.

Your key questions answered

* What was the size of the NAFTA pharmaceuticals market by value in 2014?
* What will be the size of the NAFTA pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the NAFTA pharmaceuticals market?

Table Of Contents

Pharmaceuticals: North America (NAFTA) Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
NAFTA PHARMACEUTICALS
Industry Outlook
PHARMACEUTICALS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN MEXICO
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology
About MarketLine

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.